References
Tollemar J, Andersson S, Ringden O, Tygen G (1992) A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients. Mycoses 35(9–10):215–220
Meunier F, Prentice HG, Ringden O (1991) Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. J Antimicrob Chemother 28 [Suppl B]:83–91
Jankneft R, Siem de Marie, Bakker-Woudenberg IAJM, Crommelin DJA (1992) Liposomal and lipid formulations of amphotericin B. Clin Pharmacokinet 23:279–291
Golper TA (1991) Drug removal during continuous hemofiltration or haemodialysis. In: Siebet HG, Mann H, Stummvoll HK (eds) Continuous hemofiltration. Contrib Nephrol, Karger, Basel, 93:110–116
Humphreys H, Oliver DA, Winter R, Warnock DA (1994) Liposomal amphotericin B and continuous venous-venous haemofiltration. J Antimicrob Chemother 33:1071
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tomlin, M., Priestley, G.S. Elimination of liposomal amphotericin by hemodiafiltration. Intensive Care Med 21, 699–700 (1995). https://doi.org/10.1007/BF01711556
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01711556